Search results

Articles (5)

Journals (0)

1-5 of 5 results for 177LU

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessReview articleFirst published 2022

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review

Isabel Heidegger, Claudia Kesch, Alexander Kretschmer [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published April, 2003

Three-Dimensional Dose Model for the Comparison of 177 Lu-HuCC49ΔCH2 and 177 Lu-HuCC49 Radioimunotherapy in Mice Bearing Intraperitoneal Xenografts

Peter L. Roberson, Shigeru Yokoyama, Buck E. Rogers [...]

Cancer Biotherapy and Radiopharmaceuticals

Open accessResearch articleFirst published 2023

Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)

Louise Emmett, Nikeith John, Sarennya Pathmanandavel [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published August, 2003

Biodistribution and Dosimetry of 177 Lu-Labeled [DOTA 0,Tyr 3 ]Octreotate in Male Nude Mice with Human Small Cell Lung Cancer

Anneli Schmitt, Peter Bernhardt, Ola Nilsson [...]

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published 2025

Ultrasound-Mediated Microbubble Disruption to Enhance Radiopharmaceutical Access to the Tumor Microenvironment in Immune-Resistant Lung Carcinoma

Xue Yu, Shuai Zheng, Long Zhao [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results

Articles (5)

Journals (0)

1-5 of 5 results for 177LU

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessReview articleFirst published 2022

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review

Isabel Heidegger, Claudia Kesch, Alexander Kretschmer [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published April, 2003

Three-Dimensional Dose Model for the Comparison of 177 Lu-HuCC49ΔCH2 and 177 Lu-HuCC49 Radioimunotherapy in Mice Bearing Intraperitoneal Xenografts

Peter L. Roberson, Shigeru Yokoyama, Buck E. Rogers [...]

Cancer Biotherapy and Radiopharmaceuticals

Open accessResearch articleFirst published 2023

Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)

Louise Emmett, Nikeith John, Sarennya Pathmanandavel [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published August, 2003

Biodistribution and Dosimetry of 177 Lu-Labeled [DOTA 0,Tyr 3 ]Octreotate in Male Nude Mice with Human Small Cell Lung Cancer

Anneli Schmitt, Peter Bernhardt, Ola Nilsson [...]

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published 2025

Ultrasound-Mediated Microbubble Disruption to Enhance Radiopharmaceutical Access to the Tumor Microenvironment in Immune-Resistant Lung Carcinoma

Xue Yu, Shuai Zheng, Long Zhao [...]

Cancer Biotherapy and Radiopharmaceuticals